Targeting a Common Pathway in Genetic Forms of Obesity

RARECast - A podcast by RARECast - Thursdays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Categories:

David Meeker, CEO of Rhythm, discusses genetic obesities, the company’s drug Imcivree, and his plans to expand the use of the drug beyond the initial approved indications.

Visit the podcast's native language site